Apellis Pharmaceuticals, Inc. (APLS): Price and Financial Metrics
APLS Price/Volume Stats
| Current price | $19.75 | 52-week high | $41.94 |
| Prev. close | $19.35 | 52-week low | $16.10 |
| Day low | $19.41 | Volume | 1,082,900 |
| Day high | $19.92 | Avg. volume | 2,188,895 |
| 50-day MA | $18.23 | Dividend yield | N/A |
| 200-day MA | $25.12 | Market Cap | 2.48B |
APLS Stock Price Chart Interactive Chart >
Apellis Pharmaceuticals, Inc. (APLS) Company Bio
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The company was founded in 2009 and is based in Crestwood, Kentucky.
APLS Price Returns
| 1-mo | 11.20% |
| 3-mo | N/A |
| 6-mo | -34.02% |
| 1-year | -49.99% |
| 3-year | -55.88% |
| 5-year | -39.31% |
| YTD | -38.11% |
| 2024 | -46.69% |
| 2023 | 15.76% |
| 2022 | 9.37% |
| 2021 | -17.34% |
| 2020 | 86.81% |
Loading social stream, please wait...